Clinical trial
Role of Salbutamol in the Management of Transient Tachypnea of the New Born
NCT06921291 is registered in ClinicalTrials.gov with Khyber Teaching Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Salbutamol in the Management of Transient Tachypnea of the New Born
- Lead sponsor
- Khyber Teaching Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 1, 2024
- Completion date
- December 31, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ttn